| Due Diligence for Asset Managers |
|---|
|
Analyze the public filings of asset managers Dive into the EDGAR, IAPD, CAFR source data |
|
⚲
|
| Keyboard |
| Artiva Biotherapeutics Inc | |
|---|---|
| Ticker | ARTV |
| CIK # | 0001817241 |
| CUSIP | 04317A107 |
| Sector | Life Sciences - Biological Products, (No Disgnostic Substances) |
| Address | 5505 Morehouse Drive, San Diego, CA 92121 |
| Source | [EDGAR] |
| Reg D Offering (Form D) | Filed | Raised | Terms |
|---|---|---|---|
| Artiva Biotherapeutics Inc | 2021-04-05 | 120.0 M | Exemption: 506(b) · Duration: One year or less · Revenue: Decline to Disclose |
| CIK | Filing | 2011 - 2026 |
|---|---|---|
| [0001817241] | 10-K | |
| [0001817241] | 10-Q | |
| [0001817241] | 3 | |
| [0001817241] | 4 | |
| [0001817241] | 8-K | |
| [0001817241] | D | |
| [0001817241] | SC 13D | |
| [0001817241] | SC 13G |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed | % Owned |
|---|---|---|---|
| Viking Global Investors LP | Artiva Biotherapeutics Inc | [2026-05-18] | 0.0 |
| BlackRock Inc | Artiva Biotherapeutics Inc | [2025-04-23] | 0.0 |
| venBio Global Strategic Fund III LP | Artiva Biotherapeutics Inc | [2024-08-01] | 7.8 |
| Venrock Healthcare Capital Partners III LP | Artiva Biotherapeutics Inc | [2024-08-01] | 6.9 |
| 5AM Ventures VI LP | Artiva Biotherapeutics Inc | [2024-08-01] | 5.0 |
| GC Corp | Artiva Biotherapeutics Inc | [2024-07-29] | 819419.6 |
| RA Capital Management LP | Artiva Biotherapeutics Inc | [2024-07-29] | 42.3 |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Huston Thad Allen
Common Stock
|
2026-03-10 | Grant | 220,000 | $0.00 | |
|
Sorg Elaine K
Director Stock Option (Right to Buy) · derivative
|
2026-02-18 | Grant | 27,500 | $0.00 | |
|
Horan Christopher
Common Stock
|
2026-02-15 | Tax withheld | 2,187 | $4.00 | 8,748 |
|
Horan Christopher
Common Stock
|
2026-02-15 | Grant | 117,300 | $0.00 | |
|
Raymon Heather
Common Stock
|
2026-02-15 | Grant | 46,000 | $0.00 | |
|
Bush Jennifer
Common Stock
|
2026-02-15 | Grant | 117,300 | $0.00 | |
|
Banerjee Subhashis
Common Stock
|
2026-02-15 | Grant | 102,000 | $0.00 | |
|
Aslan Fred
Common Stock
|
2026-02-15 | Tax withheld | 14,600 | $4.00 | 58,400 |
|
Aslan Fred
Common Stock
|
2026-02-15 | Grant | 366,850 | $0.00 | |
|
Bush Jennifer
Common Stock
|
2026-02-15 | Tax withheld | 3,515 | $4.00 | 14,060 |
|
Raymon Heather
Common Stock
|
2026-02-15 | Tax withheld | 1,521 | $4.00 | 6,084 |
|
Aslan Fred
Common Stock
|
2025-12-15 | Sell | 3,187 | $6.00 | 19,122 |
|
Aslan Fred
Employee Stock Option (Right to Buy) · derivative
|
2025-12-12 | Disposed to issuer | 113,999 | ||
|
Raymon Heather
Common Stock
|
2025-12-12 | Grant | 67,253 | $0.00 | |
|
Horan Christopher
Common Stock
|
2025-12-12 | Grant | 107,156 | $0.00 | |
|
Bush Jennifer
Common Stock
|
2025-12-12 | Grant | 84,877 | $0.00 | |
|
Aslan Fred
Common Stock
|
2025-12-12 | Grant | 869,136 | $0.00 | |
|
Raymon Heather
Employee Stock Option (Right to Buy) · derivative
|
2025-12-12 | Disposed to issuer | 14,819 | ||
|
Raymon Heather
Employee Stock Option (Right to Buy) · derivative
|
2025-12-12 | Disposed to issuer | 12,539 | ||
|
Raymon Heather
Employee Stock Option (Right to Buy) · derivative
|
2025-12-12 | Disposed to issuer | 11,399 | ||
| showing 20 of 127 most recent transactions | |||||
| 13F Ownership Over Time | Holders | Shares Held |
|---|---|---|
| 2026-03-31 | 40 | 16,834,466 |
| 2025-12-31 | 34 | 16,956,122 |
| 2025-09-30 | 40 | 18,156,777 |
| 2025-06-30 | 48 | 18,503,995 |
| 2025-03-31 | 54 | 20,919,893 |
| 2024-12-31 | 58 | 21,161,524 |
| 2024-09-30 | 50 | 20,740,433 |
| Form 13F Holdings | ||||
|---|---|---|---|---|
| Firm | Period | DFND | Voting | Shares |
| Simplify Asset Management Inc | [2026-06-30] | SOLE | 101,355 | 101,355 | Prev | Page 1 | Next |